Skip to main content Accessibility help

Smell identification function as a severity and progression marker in Alzheimer's disease

  • Latha Velayudhan (a1) (a2), Megan Pritchard (a2), John F. Powell (a2), Petroula Proitsi (a2) and Simon Lovestone (a2)...


Background: Olfactory dysfunction, impaired smell identification in particular, is known as a diagnostic and a marker of conversion in Alzheimer's disease (AD). We aimed to evaluate the associations of olfactory identification impairments with cognition, illness severity, and progression in AD patients.

Methods: Fifty-seven outpatients with late onset mild to moderate AD and 24 elderly non-demented controls (NDC) were assessed, at baseline and after three months, for Mini-Mental State Examination (MMSE), University of Pennsylvania Smell Identification Test (UPSIT), and Bristol Activities of Daily Living and Neuropsychiatry Inventory. AD participants were classified as Rapid Cognitive Decliners (RCD) defined on a priori with a loss of ≥2 points in MMSE within the previous six months.

Results: AD participants had lower olfactory scores than NDC. RCD had lower olfaction scores compared with Non-Rapid Cognitive Decliners (NRCD). Although the baseline UPSIT scores were associated with baseline MMSE scores, it did not interact significantly with change in MMSE over the follow-up period. Using a median split for olfactory scores, the AD participants were classified as Rapid Olfactory Progressors (ROP) (UPSIT ≤ 15) and Slow Olfactory Progressors correlating significantly with RCD/NRCD groups. The ROP group with higher olfactory impairment indicated more symptomatic illness or severity, i.e. lower cognition, higher functional dependence, and presence of behavioral symptoms.

Conclusions: Our study supports association of smell identification function with cognition and its utility as an adjunct clinical measure to assess severity in AD. Further work, including larger longitudinal studies, is needed to explore its value in predicting AD progression.


Corresponding author

Correspondence should be addressed to: Dr Latha Velayudhan, Senior Clinical Research Fellow, Psychiatry for the Elderly, Academic Department, Leicester General Hospital, Leicester LE5 4PW, UK. Phone: +44-0116-258-4597; Fax: +44-0116-273-1115. Email:


Hide All
Attems, J., Konig, C., Huber, M., Lintner, F. and Jellinger, K. A. (2005). Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. Journal of Alzheimer's Disease, 8, 5762.
Bahar-Fuchs, A., Moss, S., Rowe, C. and Savage, G. (2011). Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease. International Psychogeriatrics, 23, 10971106.
Behl, P., Stefurak, T. L. and Black, S. E. (2005). Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease. The Canadian Journal of Neurological Sciences, 32, 140151.
Bucks, R. S., Ashworth, D. L., Wilcock, G. K. and Siegfried, K. (1996). Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age and Ageing, 25, 113120.
Christen-Zaech, al. (2003). Early olfactory involvement in Alzheimer's disease. The Canadian Journal of Neurological Sciences, 30, 2025.
Copeland, J. al. (1999). Undifferentiated dementia, Alzheimer's disease and vascular dementia: age- and gender-related incidence in Liverpool. The MRC-ALPHA Study. The British Journal of Psychiatry, 175, 433438.
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 23082314.
Devanand, D. al. (2000). Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. American Journal of Psychiatry, 157, 13991405.
Devanand, D. al. (2008). Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biological Psychiatry, 64, 871879.
de Wijk, R. A. and Cain, W. S. (1994). Odor quality: discrimination versus free and cued identification. Perception & Psychophysics, 56, 1218.
Doty, R. L., McKeown, D. A., Lee, W. W. and Shaman, P. (1995). A study of the test-retest reliability of ten olfactory tests. Chemical Senses, 20, 645656.
Doty, R. L., Reyes, P. F. and Gregor, T. (1987). Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Research Bulletin, 18, 597600.
Doty, R. L., Shaman, P., Kimmelman, C. P. and Dann, M. S. (1984). University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. The Laryngoscope, 94, 176178.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Foster, J., Sohrabi, H., Verdile, G. and Martins, R. (2008). Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction. International Psychogeriatrics, 20, 853855.
Gauthier, S., Vellas, B., Farlow, M. and Burn, D. (2006). Aggressive course of disease in dementia. Alzheimer's & Dementia, 2, 210217.
Gray, A. J., Staples, V., Murren, K., Dhariwal, A. and Bentham, P. (2001). Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry, 16, 513517.
Hidalgo, J., Chopard, G., Galmiche, J., Jacquot, L. and Brand, G. (2011). Just noticeable difference in olfaction: a discriminative tool between healthy elderly and patients with cognitive disorders associated with dementia. Rhinology, 49, 513518.
Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A. and Martin, R. L. (1982). A new clinical scale for the staging of dementia. The British Journal of Psychiatry, 140, 566572.
Kraemer, H. C., Tinklenberg, J. and Yesavage, J. A. (1994). ‘How far’ vs ‘how fast’ in Alzheimer's disease. The question revisited. Archives of Neurology, 51, 275279.
Larsson, M., Semb, H., Winblad, B., Amberla, K., Wahlund, L. O. and Backman, L. (1999). Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support. Neuropsychology, 13, 4753.
Li, W., Howard, J. D. and Gottfried, J. A. (2010). Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease. Brain, 133, 27142726.
Makowska, I., Kloszewska, I., Grabowska, A., Szatkowska, I. and Rymarczyk, K. (2011). Olfactory deficits in normal aging and Alzheimer's disease in the polish elderly population. Archives of Clinical Neuropsychology, 26, 270279.
Marra, C., Silveri, M. C. and Gainotti, G. (2000). Predictors of cognitive decline in the early stage of probable Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 11, 212218.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.
Mesholam, R. I., Moberg, P. J., Mahr, R. N. and Doty, R. L. (1998). Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Archives of Neurology, 55, 8490.
Morgan, C. D. and Murphy, C. (2002). Olfactory event-related potentials in Alzheimer's disease. Journal of International Neuropsychological Society, 8, 753763.
Mullol, al. (2012). Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study). BMJ Open, 2, e001256. doi:10.1136/bmjopen-2012-001256.
Murphy, C., Schubert, C. R., Cruickshanks, K. J., Klein, B. E., Klein, R. and Nondahl, D. M. (2002). Prevalence of olfactory impairment in older adults. Journal of American Medical Association, 288, 23072312.
Rahayel, S., Frasnelli, J. and Joubert, S. (2012). The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis. Behavioural Brain Research, 231, 6074.
Richardson, J. T. and Zucco, G. M. (1989). Cognition and olfaction: a review. Psychological Bulletin, 105, 352360.
Schab, F. R. (1991). Odor memory: taking stock. Psychological bulletin, 109, 242251.
Schubert, C. R., Carmichael, L. L., Murphy, C., Klein, B. E., Klein, R. and Cruickshanks, K. J. (2008). Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. Journal of American Geriatric Society, 56, 15171521.
Serby, M., Larson, P. and Kalkstein, D. (1991). The nature and course of olfactory deficits in Alzheimer's disease. American Journal of Psychiatry, 148, 357360.
Sluimer, J. al. (2008). Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology, 70, 18361841.
Sohrabi, H. al. (2009). Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals. Journal of Alzheimer's Disease, 17, 135142.
Sohrabi, H. al. (2012). Olfactory discrimination predicts cognitive decline among community-dwelling older adults. Translational Psychiatry, 2, e118.
Sun, G. H., Raji, C. A., Maceachern, M. P. and Burke, J. F. (2012). Olfactory identification testing as a predictor of the development of Alzheimer's dementia: a systematic review. The Laryngoscope, 122, 14551462.
Swan, G. E. and Carmelli, D. (2002). Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology, 21, 5867.
Thambisetty, al. (2010). Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Archives of General Psychiatry, 67, 739748.
Velayudhan, L. and Lovestone, S. (2009). Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil. Journal of Clinical Psychopharmacology, 29, 387390.
Velayudhan, al. (2012). Plasma transthyretin as a candidate marker for Alzheimer's disease. Journal of Alzheimer's Disease, 28, 369375.
Wang, al. (2010). Olfactory deficit detected by fMRI in early Alzheimer's disease. Brain Research, 1357, 184194.
Westervelt, H. J., Carvalho, J. and Duff, K. (2007). Presentation of Alzheimer's disease in patients with and without olfactory deficits. Archives of Clinical Neuropsychology, 22, 117122.
Wilson, R. S., Arnold, S. E., Tang, Y. and Bennett, D. A. (2006). Odor identification and decline in different cognitive domains in old age. Neuroepidemiology, 26, 6167.
Wilson, R. S., Schneider, J. A., Arnold, S. E., Tang, Y., Boyle, P. A. and Bennett, D. A. (2007). Olfactory identification and incidence of mild cognitive impairment in older age. Archives of General Psychiatry, 64, 802808.


Related content

Powered by UNSILO

Smell identification function as a severity and progression marker in Alzheimer's disease

  • Latha Velayudhan (a1) (a2), Megan Pritchard (a2), John F. Powell (a2), Petroula Proitsi (a2) and Simon Lovestone (a2)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.